Anti-Sumo-2/3 antibody, Rat monoclonal

MFCD03455941

NA.41

Monoclonal Anti-Sumo-2/3 (rat IgG2a isotype) is derived from the hybridoma 3H12 produced by the fusion of mouse myeloma cells and splenocytes from rat immunized with a human SUMO3 fusion protein.
Small ubiquitin-like modifier 3 (SUMO3) is encoded by the gene mapped to human chromosome 21q22.3. The protein belongs to the ubiquitin-like protein family and is expressed mainly in cytoplasm.

human SUMO3 fusion protein

Monoclonal Anti-Sumo-2/3 has been used in immunoblotting and immunocytochemistry.

Small ubiquitin-like modifier (SUMO) was identified as a post-translational protein modifier.
Small ubiquitin-like modifier 3 (SUMO3) plays a vital role in enhancing cellular responses to environmental stress. It acts as a key element of the leukemogenic network in transient myeloproliferative disorder (TMD) of the newborn/acute megakaryoblastic leukaemia (AMKL).

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide

unconjugated

purified from hybridoma cell culture

primary antibodies

3H12, monoclonal

buffered aqueous solution

~11 kDa

mouse, human, rat

~1.0 mg/mL

immunocytochemistry: suitable
western blot: 2-4 μg/mL using HeLa cell nuclear extract

P55854

dry ice

−20℃

human ... SUMO3(6612)
mouse ... Sumo3(20610)
rat ... Sumo3(499417)

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

12 - Non Combustible Liquids